Trial intelligence / Profile preview

N9741: Chemotherapy Regimens in Advanced Colorectal Cancer

NCT00003594Phase 3Completed

Sponsor
Cancer and Leukemia Group B
Start
Oct 1998
Primary completion
Oct 2004
Modality
DNA Intercalators/Alkylators
Countries
4
01

Overview

A Phase 3 trial of oxaliplatin in colorectal cancer (CRC), sponsored by Cancer and Leukemia Group B. Started Oct 1998; status: completed.

02

Drugs

oxaliplatin
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00003594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call